to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Can big data provide the cure for what ails the U.S. healthcare system? While some might consider data analytics a panacea to help achieve a more effective, efficient healthcare system, there are plenty of challenges to overcome, according to participants in a panel on "Fact or Fiction: Healthcare Big Data," at the recent 2013 StrataRx conference in Boston.
After the terrorist attacks of September 11, 2001, the Central Intelligence Agency enlisted the help of a Palo Alto-based startup, Palantir Technologies, to gather and analyze huge amounts of data to identify and understand terrorist groups and thwart their efforts.
As politicians have continued to debate the pros and cons of the Affordable Care Act, aka "Obamacare," some federal health officials have been working to spread the word about another aspect of healthcare reform: the move to give consumers more access to their own healthcare data.
For those hoping to use data analytics as a tool to help improve the U.S. healthcare system, patient records represent a potential gold mine of information to identify the most effective and cost-efficient practices to diagnose and treat specific conditions.
As panelists at the 2013 StrataRx conference in Boston expounded last week on the potential of “big data” in healthcare, another, auspicious industry event was taking place not far away.
With only three quarters completed, 2013 has already been a record year for venture funding in digital health, according to San Francisco-based health IT incubator Rock Health, which has been tracking deals in the space since 2011.
Even if legal attempts to derail the US healthcare reform bill were successful, it wouldn’t really matter.
Are bioresorbable stents from one company better than another? Arterial Remodeling Technologies thinks so. The company boasts that its stents offer faster and smoother bioresorption and crack-free expansion.
Healthcare investment in seed-stage companies is falling, and healthcare deals decreased as well. Read more to find out the details about how new healthcare businesses fared in a recent report.
In medical business news, imaging software firm Riverain Medical hopes to boost sales of a product that helps detect lung cancer. The company’s technology allows radiologists to see behind ribs and clavicles to get a better view of pulmonary nodules. Read more about this company’s promising future.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.